Hence, several approaches to TB vaccine development employing the use of proapoptotic vaccine candidates in the form of DNA vaccine, recombinant Mtb, or recombinant BCG platforms have been tested, demonstrating the induction of IFN-γ production and protection against Mtb in mice [101–104]. Here, IFNG is linked to tuberculosis.